Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up
- PMID: 11422435
- DOI: 10.1046/j.1468-1331.2001.00224.x
Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up
Comment in
-
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine.Eur J Neurol. 2002 Sep;9(5):545. doi: 10.1046/j.1468-1331.2002.04455.x. Eur J Neurol. 2002. PMID: 12220392 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
